Bausch + Lomb (BLCO) gained about 3% in Tuesday’s session, with trading chatter centering on renewed attention to the company’s multi-year growth framework and the durability of its 2026 setup. The stock’s move appears to be sentiment-driven rather than tied to a single same-day corporate release, with investors pointing back to management’s targets for 2026–2028 execution and cash generation as key supports for the equity story. (ir.bausch.com)

Management has communicated a target of 5–7% constant-currency revenue CAGR through 2028 alongside double-digit adjusted EPS growth (excluding acquired IPR&D) from 2026–2028, a combination that can matter for a mid-teens stock if investors believe operating leverage and mix can improve. BLCO also issued full-year 2026 guidance with its Q4/FY 2025 results, which has helped anchor expectations and refocus the debate on margin trajectory and execution in newer launches. (ir.bausch.com)

Adding to the constructive tone, a Form 4 filing shows a director purchase of 4,500 shares in early March at about $17.68 per share. While the transaction is not a fundamental catalyst by itself, insider buying can reinforce a view that the board sees value at current levels—especially when paired with reiterated multi-year targets. (sec.gov)

The next major catalyst is the upcoming earnings report (market calendars currently show early May 2026), which could reset near-term expectations around product momentum and profitability. Into that event, investors are likely to focus on updates around 2026 revenue/EBITDA cadence and any incremental commentary that supports the longer-term 2028 framework. (investing.com)